Journal
SCANDINAVIAN CARDIOVASCULAR JOURNAL
Volume 43, Issue 1, Pages 72-79Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14017430802180449
Keywords
Bradykinin; pharmacological preconditioning; cytokine; coronary artery bypass grafting
Categories
Funding
- Medical Research Fund of Tampere University Hospital
- CIMO foundation of Finland
- Tampere Tuberculosis Foundation
- Academy of Finland
Ask authors/readers for more resources
Objective. The present study was designed to investigate the cardioprotective effect of exogenous administration of bradykinin (BK) in cardiac surgery. Methods. Forty-one patients who were scheduled for isolated coronary artery bypass grafting (CABG) were randomized into Control group and BK group. BK patients received 25 g bradykinin infusion for 7 minutes before the cardiopulmonary bypass (CPB). Release of cardiac specific troponin I (TnI) and creatine kinase cardiac isoenzyme (CK-MB) was recorded. Perioperative circulating cytokine interleukin (IL)-6, 8 and 10 were measured. Results. There was no significant difference in TnI between groups. However, BK patients released significantly less CK-MB than the controls (p =0.043). Systemic plasma levels of IL-6, IL-8 and IL-10 increased significantly after reperfusion in both groups as compared with baseline (p 0.05). The ratio of IL-8 to IL-10 was significantly lower in BK groups than in controls (p =0.03). Conclusions. We conclude that exogenous administration of BK prior to CPB in CABG patients attenuates ischemic myocardial injury. It also shifts the circulating inflammatory cytokine balance towards the anti-inflammatory direction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available